Literature DB >> 8011681

Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and HepG2 cells.

R Gebhardt1, H Beck, K G Wagner.   

Abstract

Exposure of primary rat hepatocytes and human HepG2 cells to allicin and ajoene resulted in the concentration-dependent inhibition of cholesterol biosynthesis at different steps of this metabolic pathway. At low concentrations of ajoene sterol biosynthesis from [14C]acetate in rat hepatocytes was decreased by 18% with an IC50-value of 15 microM, while allicin was almost uneffective. In HepG2 cells, both compounds significantly inhibited sterol biosynthesis by 14% and 19% with IC50-values of 7 and 9 microM for allicin and ajoene, respectively. This inhibition was exerted at the level of HMG-CoA-reductase as revealed by the absence of inhibition, if [14C]acetate was replaced by [14C]mevalonate as a precursor, and by direct determination of enzyme activity. At somewhat higher concentrations inhibition of cholesterol biosynthesis by both, allicin and ajoene, was also observed at late steps resulting in the accumulation of the precursor lanosterol. Alliin instead was completely inactive. In the case of allicin, small amounts of dihydrolanosterol and 7-dehydrocholesterol were formed at intermediate concentrations of 5-10 microM. From these results it is concluded that a major point of inhibition at the late steps occurs at the level of lanosterol 14 alpha-demethylase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011681     DOI: 10.1016/0005-2760(94)90222-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinoma.

Authors:  Yingyi Wang; Zhao Sun; Shuchang Chen; Yuchen Jiao; Chunmei Bai
Journal:  Tumour Biol       Date:  2015-10-14

2.  Garlic ameliorates hyperlipidemia in chronic aminonucleoside nephrosis.

Authors:  J Pedraza-Chaverrí; O N Medina-Campos; M A Granados-Silvestre; P D Maldonado; I M Olivares-Corichi; R Hernández-Pando
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

3.  Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures.

Authors:  R Gebhardt; H Beck
Journal:  Lipids       Date:  1996-12       Impact factor: 1.880

4.  Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation.

Authors:  Nicola Ferri; Kohei Yokoyama; Martin Sadilek; Rodolfo Paoletti; Rafael Apitz-Castro; Michael H Gelb; Alberto Corsini
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

5.  A review of studies of garlic (Allium sativum) on serum lipids and blood pressure before and after 1994: does the amount of allicin released from garlic powder tablets play a role?

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2005

6.  Effect of garlic on blood pressure: a meta-analysis.

Authors:  Hai-Peng Wang; Jing Yang; Li-Qiang Qin; Xiang-Jun Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-05       Impact factor: 3.738

7.  High hydrostatic pressure extract of garlic increases the HDL cholesterol level via up-regulation of apolipoprotein A-I gene expression in rats fed a high-fat diet.

Authors:  Seohyun Lee; Hyunjin Joo; Chong-Tai Kim; In-Hwan Kim; Yangha Kim
Journal:  Lipids Health Dis       Date:  2012-06-19       Impact factor: 3.876

8.  Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic.

Authors:  L Liu; Y Y Yeh
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

9.  Allicin modulates the antioxidation and detoxification capabilities of primary rat hepatocytes.

Authors:  Chih-Chung Wu; Yung-Lin Chu; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2012-10

10.  A Comparison of the Antibacterial and Antifungal Activities of Thiosulfinate Analogues of Allicin.

Authors:  Roman Leontiev; Nils Hohaus; Claus Jacob; Martin C H Gruhlke; Alan J Slusarenko
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.